Respiratory tract infection - Open Access .click

Results 191 to 200 of about 570,791 (297)

Chemistry – A European Journal, EarlyView.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik +3 more
wiley +1 more source

Analysis of influenza A, influenza B and <i>Mycoplasma pneumoniae</i> infection in children hospitalized with acute respiratory tract infection in Xi'an from 2021 to 2023. [PDF]

Front Public Health
Zhang H, Zhuang G, Zhao B, Wang Z.
europepmc +1 more source

Serious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative

Clinical Pharmacology &Therapeutics, EarlyView.
The U.S. Food and Drug Administration (FDA) used an Active Postmarket Risk Identification and Analysis (ARIA) system to address a safety issue (serious infection) identified during clinical review of an application to market ustekinumab as a treatment for Crohn's disease (CD). FDA used an active‐comparator new‐user cohort design, data from six Sentinel
Joel L. Weissfeld +9 more
wiley +1 more source

Diagnostic value of metagenomic next-generation sequencing in the etiological diagnosis of lower respiratory tract infection. [PDF]

Sci Rep
Wang R, Wang H, Jiang J, Xu S, Dong M.
europepmc +1 more source

Concomitant 5‐Aminosalicylic Acid Does Not Affect the Efficacy of Janus Kinase Inhibitors in Ulcerative Colitis

Clinical Pharmacology &Therapeutics, EarlyView.
We evaluated whether concomitant 5‐aminosalicylic acid (5‐ASA) influences clinical remission in patients with ulcerative colitis (UC) receiving Janus kinase inhibitors (JAKi). In this retrospective, multicenter cohort study, UC patients receiving tofacitinib (n = 181), upadacitinib (n = 313), or filgotinib (n = 139) were included.
Antonio Tursi +100 more
wiley +1 more source

Construction of a predictive model for lower respiratory tract infection in children with leukemia after chimeric antigen receptor T cell therapy. [PDF]

Transl Pediatr
Tao L, He M, Zhang X, Sun J, Shen N, Shen B. +5 more
europepmc +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley +1 more source

Parent Preferences for Acute Respiratory Tract Infection Care.

JAMA Netw Open
Hanmer J +5 more
europepmc +1 more source

Multi-dimensional epidemiology of pediatric acute respiratory tract infection in Ningbo, China (2020-2024): age-specific susceptibility, pathogen dynamics, and epidemiological trends. [PDF]

Front Cell Infect Microbiol
Jiang M +6 more
europepmc +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source

humans
respiratory tract infections
3. good health

pneumonia
child
anti-bacterial agents

child, preschool
risk factors
upper respiratory tract infection